Ładuje się......
Mibefradil, a T‐type Ca(2+) channel blocker also blocks Orai channels by action at the extracellular surface
BACKGROUND AND PURPOSE: Mibefradil, a T‐type Ca(2+) channel blocker, has been investigated for treating solid tumours. However, its underlying mechanisms are still unclear. Here, we have investigated the pharmacological actions of mibefradil on Orai store‐operated Ca(2+) channels. EXPERIMENTAL APPRO...
Zapisane w:
| Wydane w: | Br J Pharmacol |
|---|---|
| Główni autorzy: | , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
John Wiley and Sons Inc.
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6780027/ https://ncbi.nlm.nih.gov/pubmed/31271653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14788 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|